ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,999Medicare Part D Prescriptions Filled, Including Refills

Rank: 48 out of 372

$543K Total Retail Price of All Prescriptions

Rank: 56 out of 372

582 Patients Receiving at Least One Drug in Part D
76% Patients 65 Years and Older
2% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Puerto Rico
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $45 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 809 616 206 1 1
METFORMIN HCL 530 408 120 2 3
RANITIDINE HCL 489 342 135 3 8
OMEPRAZOLE 444 334 128 4 9
AMLODIPINE BESYLATE 405 326 108 5 2
LOSARTAN POTASSIUM 373 259 102 6 5
LEVOTHYROXINE SODIUM 347 252 80 7 10
LOSARTAN-HYDROCHLOROTHIAZIDE 328 255 76 8 11
ENALAPRIL MALEATE 304 242 88 9 7
ALENDRONATE SODIUM 293 258 79 10 24
GABAPENTIN 283 157 68 11 4
ATORVASTATIN CALCIUM 274 225 83 12 13
SYNTHROID 270 230 63 13 6
LANTUS 263 181 50 14 43
CLOPIDOGREL 230 196 60 15 14
HYDROCHLOROTHIAZIDE 203 146 44 16 22
CARVEDILOL 200 181 40 17 25
FUROSEMIDE 168 141 43 18 23
METOPROLOL TARTRATE 167 125 43 19 19
FLUTICASONE PROPIONATE 162 104 74 20 53
GLIPIZIDE XL 144 97 28 21 110
PENTOXIFYLLINE 137 95 37 22 123
MONTELUKAST SODIUM 135 86 42 23 35
GLIPIZIDE 130 82 30 24 30
SERTRALINE HCL 124 105 36 25 29
IRBESARTAN 124 108 27 25 33
ISOSORBIDE MONONITRATE ER 119 101 33 27 31
ZOLPIDEM TARTRATE 114 89 29 28 16
TRAMADOL HCL-ACETAMINOPHEN 113 88 48 29 20
METOPROLOL SUCCINATE 113 74 30 29 21
HUMULIN 70-30 112 93 15 31 48
CLOTRIMAZOLE-BETAMETHASONE 107 83 56 32 52
PAROXETINE HCL 107 73 26 32 38
QUINAPRIL HCL 107 76 25 32 136
HUMULIN N 107 50 21 32 60
DIOVAN 105 58 18 36 71
ATENOLOL 105 100* 23 36 15
LISINOPRIL 104 67 23 38 17
GEMFIBROZIL 101 62 29 39 69
DONEPEZIL HCL 97 92* 26 40 41
NAPROXEN 96 72 57 41 129
PANTOPRAZOLE SODIUM 92 70 31 42 36
FAMOTIDINE* 92 79 37 42 40
PRAVASTATIN SODIUM 92 72 21 42 26
WARFARIN SODIUM 88 88 16 45 55
FENOFIBRATE* 86 60 40 46 42
TAMSULOSIN HCL 83 72 18 47 27
PROVENTIL HFA 83 50 17 47 158
NIFEDIPINE ER 82 77* 18 49 125
NABUMETONE 74 26 44 50 44
QVAR 72 67* 23 51 164
NAMENDA 71 71 18 52 64
EVISTA 70 51 17 53 62
GLIPIZIDE ER 68 63* 18 54 121
CLONAZEPAM 67 50 21 B 55 12
LANSOPRAZOLE 66 52 17 56 80
PROAIR HFA 64 48 26 57 92
SPIRONOLACTONE 62 50 18 58 81
AZITHROMYCIN 59 42 54 59 70
DOXAZOSIN MESYLATE 55 55 12 60 32
FENOFIBRATE* 52 47* 14 61 42
GLIMEPIRIDE 52 41 11 61 18
LYRICA 52 36 15 61 100
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 29, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.